²é¿´: 1585  |  »Ø¸´: 4

laberlee

ľ³æ (СÓÐÃûÆø)

[½»Á÷] ¡¾ÇóÖú¡¿ÇóÓйذ¢´ïľµ¥¿¹µÄ·¢ÏÖ¡¢ÁÙ´²Ç°Ñо¿¡¢ÁÙ´²Ñо¿£¬FDAÉêÇ룬¼¼Êõ×ªÒÆµÄÓйØÎÄÏ ÒÑÓÐ3È˲ÎÓë

ÏÈллÁË¡£¡£ÎÒʵÔÚËѲ»µ½
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

laberlee

ľ³æ (СÓÐÃûÆø)

Ã×ÓÐÈË»Ø
2Â¥2011-04-16 00:47:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hardee

Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)

´Ë²ÝÓÐÖ÷~

¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
chinarencxp(½ð±Ò+1): ¹ÄÀø»ý¼«½»Á÷ 2011-04-16 22:20:18
Ëæ±ã¿´¿´°É£º

Title: Adalimumab

CAS Registry Number: 331731-18-1

CAS Name: Anti-(human tumor necrosis factor) immunoglobulin G1 (human monoclonal D2E7 heavy chain) disulfide with human monoclonal D2E7 light chain, dimer

Manufacturers' Codes: D2E7

Trademarks: Humira (Abbott)

Literature References: Fully human monoclonal antibody against tumor necrosis factor a (TNFa). Prepn: J. G. Salfeld et al., WO 9729131; eidem, US 6090382 (1997, 2000 both to BASF). Characterization: L. C. Santora et al., Anal. Biochem. 275, 98 (1999). Characterization of antigen binding: idem et al., ibid. 299, 119 (2001). Clinical trial in rheumatoid arthritis: A. A. den Broeder et al., Ann. Rheum. Dis. 61, 311 (2002); in combination with methotrexate: F. C. Breedveld et al., Arthritis Rheum. 54, 26 (2006); in psoriatic arthritis: P. J. Mease et al., ibid. 52, 3279 (2005). Review of pharmacology and clinical experience: K. P. Machold, J. S. Smolen, Expert Opin. Biol. Ther. 3, 351-360 (2003). Review of safety and efficacy in psoriasis and rheumatoid arthritis: T. Patel, K. B. Gordon, Dermatol. Ther. 17, 427-431 (2004); in psoriatic arthritis: P. J. Mease, Expert Opin. Biol. Ther. 5, 1491-1504 (2005).

Therap-Cat: Anti-inflammatory.

Keywords: Anti-inflammatory (Biological Response Modifier).
°²µÃ´ÙÏ¥£¬¿É¹²Æ½Éú¡£
3Â¥2011-04-16 08:36:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

laberlee

ľ³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
Originally posted by hardee at 2011-04-16 08:36:54:
Ëæ±ã¿´¿´°É£º

Title: Adalimumab

CAS Registry Number: 331731-18-1

CAS Name: Anti-(human tumor necrosis factor) immunoglobulin G1 (human monoclonal D2E7 heavy chain) disulfide with human mono ...

O(¡É_¡É)Oлл~~
4Â¥2011-04-18 15:46:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ò©µÀÈË

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

¾»ÓÉ»àÉú£¬Ã÷´Ó霳ö

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

ÒýÓûØÌû:
Originally posted by laberlee at 2011-04-18 15:46:47:
O(¡É_¡É)Oлл~~

ÄãÊÇʲô¹«Ë¾°¡
À´Ê±ºúͿȥʱÃÔ£¬¿ÕÔÚÈ˼ä×ßÕâ»Ø¡£Î´ÔøÉúÎÒË­ÊÇÎÒ£¬ÉúÎÒÖ®ºóÎÒÊÇË­£¿³¤´ó³ÉÈË·½ÖªÎÒ£¬ºÏÑÛëüëÊÓÖÊÇË­£¿²»Èç²»À´Ò²²»È¥£¬ÒàÎÞ·³ÄÕÒàÎÞ±¯¡£
5Â¥2011-06-16 13:27:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ laberlee µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼± +5 QUjhNVAcOSff 2026-09-13 6/300 2026-09-14 15:21 by Aj1rhIDL5ixY
[¿¼²©] ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 QUjhNVAcOSff 2026-09-13 4/200 2026-09-14 15:13 by Aj1rhIDL5ixY
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 QUjhNVAcOSff 2026-09-13 3/150 2026-09-14 15:09 by Aj1rhIDL5ixY
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8O.55.1.O.54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 QUjhNVAcOSff 2026-09-13 4/200 2026-09-14 15:01 by Aj1rhIDL5ixY
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +4 QUjhNVAcOSff 2026-09-13 6/300 2026-09-14 15:00 by Aj1rhIDL5ixY
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 QUjhNVAcOSff 2026-09-13 3/150 2026-09-14 14:57 by Aj1rhIDL5ixY
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8O5.5.1.O5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 s3fFTmArrBt6 2026-09-14 3/150 2026-09-14 12:35 by 40ms4Wlo4umh
[»ù½ðÉêÇë] Çó½Ì¸÷λ´óÉñ£º2026½ÌÓý²¿ÈËÎÄÉç¿ÆÇàÄê»ù½ðÏîÄ¿ºÎʱ¹«Ê¾Ñ½£¿ +5 ÔÆÑçɽÈË 2026-09-10 7/350 2026-09-14 12:11 by ecnu2013
[ÕÒ¹¤×÷] Õ㽭ʦ·¶´óѧÊÇÔõô¿ÓÎÒµÄ +6 recruit123 2026-09-09 6/300 2026-09-14 12:00 by ÈøÈÊÆäÆä¸ñ
[¿¼ÑÐ] ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 LwdutQ8HoqWP 2026-09-13 3/150 2026-09-14 11:13 by 23jxep3nCNZb
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8O5.5.1.O5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 3n8v2C8RimXI 2026-09-13 3/150 2026-09-14 10:59 by 23jxep3nCNZb
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 3n8v2C8RimXI 2026-09-13 3/150 2026-09-14 10:56 by 23jxep3nCNZb
[½Ìʦ֮¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 3n8v2C8RimXI 2026-09-13 3/150 2026-09-14 10:44 by 23jxep3nCNZb
[¿¼²©] ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 3n8v2C8RimXI 2026-09-13 3/150 2026-09-14 10:32 by 23jxep3nCNZb
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼± +3 QUjhNVAcOSff 2026-09-13 3/150 2026-09-14 10:11 by 23jxep3nCNZb
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 QUjhNVAcOSff 2026-09-13 4/200 2026-09-14 10:01 by 23jxep3nCNZb
[¿¼²©] Î÷±±¹¤Òµ´óѧ²ÄÁÏѧԺµç»¯Ñ§´«¸ÐÓë´ß»¯¿ÎÌâ×éÕÐÊÕ2027ÄêÍÆÃâÑо¿Éú¡¢²©Ê¿Éú¡¢²©Ê¿ºó +3 Âí·½Ô° 2026-09-10 4/200 2026-09-14 09:29 by ChemÕÅzz
[¿¼²©] 27Çï¼¾²ÄÁϲ©Ê¿ÉêÇëÇóÖú 10+3 Cahal1 2026-09-11 4/200 2026-09-14 08:50 by ±±¾©À³Òð±à¼­
[½Ìʦ֮¼Ò] Õ㽭ʦ·¶´óѧÊÇÔõô¿ÓÎÒµÄ +10 recruit123 2026-09-09 15/750 2026-09-13 10:45 by seaskyy
[»ù½ðÉêÇë] ÃæÉÏÓÐר¼Ò˵ʵÑéÉ豸²»ÊÇÎÒÃǵ¥Î»µÄ +6 zj_muchong 2026-09-08 8/400 2026-09-11 06:56 by suifengdao
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û